Systematic Chart Review of Carotidynia Patients

Carotidynia Clinical Trial

— TIPIC  

Official title:

Systematic Chart Review of Carotidynia Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02900872
• Other study ID #: NI_ALR_2015_3
• Status: Completed
• Phase: N/A
• First received: September 6, 2016
• Last updated: September 9, 2016
• Start date: January 2009

Study information

• Verified date: September 2016
• Source: Fondation Ophtalmologique Adolphe de Rothschild
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: The Commission nationale de l’informatique et des libertés
• Study type: Observational

Clinical Trial Summary

Systematic retrospective study of medical charts and medical imaging files, of patients consulting for acute neck pain and presenting unclassified abnormalities on dedicated vessel imaging.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. primary completion date: October 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• acute cervical tenderness or neck pain fulfilling the characteristics of an idiopathic neck pain syndrome as defined by the International Headache Society in 1988

• the performing of a diagnostic imaging like MRI, CT or US of the cervical area with a dedicated vessel analysis

• unilateral or bilateral abnormalities of common carotid, carotid bifurcation or internal carotid arteries on dedicated vessel imaging.

Exclusion Criteria:

• patients without imaging, or without dedicated vessel analysis

• patients presenting with pain caused by a clearly identified vascular disease on dedicated vessel analysis imaging such as carotid occlusion, carotid dissection, vasculitis like giant cell arteritis.

• patients with no abnormality on cervical or vessel imaging

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Carotidynia

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Presence or absence of perivascular carotid artery enlargement on dedicated vessel imaging		Within 1 week following admission	No